Brief: Medicines Co and SymBio Pharmaceuticals establish strategic partnership
06/10/2015 22:12
Oct 6 (Reuters) - Medicines Co MDCO.O : * Press release - the Medicines Company and SymBio Pharmaceuticals establish strategic partnership for ionsys (fentanyl iontophoretic transdermal system) in Japan * Financial terms of the agreement include a $10 million upfront payment and certain regulatory and commercial milestones * Says partnership includes an agreement granting SymBio an exclusive license in Japan to develop and commercialize ionsys * Says co and SymBio Pharmaceuticals establish strategic partnership for ionsys in Japan * Source text for Eikon ID:nBwbllG5ja * Further company coverage MDCO.O ((Bengaluru Newsroom; +1 646 223 8780))